9
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Protection of bronchoalveolar macrophages by granulocyte-macrophage colony-stimulating factor against dexamethasone suppression of fungicidal activity for Aspergillus fumigatus conidia

, &
Pages 509-515 | Published online: 09 Jul 2009

References

  • Anderson RJ, Schaffer LA, Olin DB, Eickhoff C. Infectious risk factors in the immunosuppressed host. Am J Med 1973; 54:453–460.
  • Gustafson TL, Schaffner W, Lavely GB, Stratton CW, Johnson HK, Hutcherson RH. Invasive aspergillosis in renal transplant recipients: correlation with corticosteriod therapy. J Infect Dis 1983; 148: 230–238.
  • Walsh TJ, Mendelsohn G. Invasive aspergillosis complicating Cushing's syndrome. Arch Intern Med 1981; 141: 1227–1228.
  • Graham S, Tucker WS. Opportunistic infections in endogenous Cushing's syndrome. Ann Intern Med 1984; 101:334–338.
  • Schaffner A. Therapeutic concentrations of glucosteroids sup-press the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. J Gun Invest 1985; 76: 1755–1764.
  • Roilides E, Blake C, Holmes A, Pizzo PA, Walsh TJ. Granulocyte-macrophage colony-stimulating factor and inter-feron-gamma prevent dexamethasone-inducedimmunosuppres-sion of antifungal monocyte activity against Aspergillus fumigatus hyphae. J Med Vet Mycol 1996; 34: 63–69.
  • Michaliszyn E, Senechal S, Martel P, deRepentigny L. Lack of involvement of nitric oxide in killing Aspergillus fumigatus
  • Robertson MD, Kerr KM, Seaton A. Killing of Aspergillus fumigatus spores by human lung macrophages: a paradoxical effect of heat-labile serum components. J Med Vet Mycol 1989; 27: 295–302.
  • Sugar AM, Brummer E, Stevens DA. Murine pulmonary macrophages: evaluation of lung lavage fluids, miniaturized monolayers, and candidacidal activity. Am Rev Respir Dis 1983; 127: 110–112.
  • Washburn RG, Gallin JI, Bennett JE. Oxidative killing of Aspergillus fumigatus by parallel MPO-dependent and indepen-dent pathways. Infect Immun 1987; 55: 2088–2092.
  • Brummer E, Morozumi PA, Vo PT, Stevens DA. Protection against pulmonary blastomycosis: adoptive transfer with T lymphocytes, but not serum, from resistant mice. Cell Immunol 1982; 73: 349–359.
  • Schaffner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorpho-nuclear phagocytes in resistance to Aspergillus. J Clin Invest 1982; 69: 617–631.
  • Levitz SM, Diamond RD. Mechanisms of resistance of Aspergillus fumigatus conidia to killing by neutrophils in vitro. J Infect Dis 1985; 152: 33–43.
  • Schaffner A, Douglas H, Braude Al, Davis CE. Killing of Aspergillus spores depends on the anatomical source. Infect Immun 1983; 42: 1109–1115.
  • Kozel TR, Wilson MA, Farrell TP, Levitz SM. Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae. Infect Immun 1989; 57: 3412–3417.
  • Condino-Neto A, Whitney C, Newburger PE. Dexamethasone but not indomethacin inhibits human phagocyte nicotinamide adenine dinucleotide phosphate oxidase activity by down regulating expression of genes encoding oxidase components. J Immunol 1998; 161: 4960–4967.
  • Natarajan U, Randhawa N, Brummer E, Stevens DA. Effect of granulocyte-macrophage colony-stimulating factor on candida-cidal activity of neutrophils, monocytes or monocyte-derived macrophages and synergy with fluconazole. J Med Microbiol 1998; 47: 359–363.
  • Vora S, Purimetla N, Brummer E, Stevens DA. Activity of voriconazole, a new triazole, combined with neutrophils or monocytes against Candida albicans: effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Antimicrob Agents Chemother 1998; 42:907–910.
  • Vora S, Chauhan S, Brummer E, Stevens DA. Activity of voriconazole combined with neutrophils or monocytes against Aspergillus fumigatug effect of granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor. Antimicrob Agents Chemother 1998; 42: 2299–2303.
  • Lim TK, Chen G-H, McDonald RA, Toews GB. Granulocyte-macrophage colony-stimulating factor overrides the immuno-suppressive function of corticosteroids on rat pulmonary dentritic cells. Stem Cells 199614: 292–299.
  • Munck A, Mendel DB, Smith LI, Orti E. Glucocorticoid receptors and actions. Am Rev Respir Dis 1990;141:52–S10.
  • Payvar F, Wrange O, Carlstedt-Duke J, Obret S, Gustafason JA, Yamamoto KR. Purified glucocorticoid receptors bind selec-tively in vitro to a cloned DNA fragment whose transcription is regulated by glucocorticoids in vivo. Proc Natl Acad Sci USA 1981; 78: 6628–6632.
  • Auphan N, Di Donato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kB activity through induction of IkB synthesis. Science 1995; 270: 286–290.
  • Rosen RL, Winestock KD, Chen G, Liu X, Henninghausen L, Finbloom DS. Granulocyte-macrophage colony-stimulating factor preferentially activates 94 kD STAT5a and an 80 kD STAT5a isoform in human blood monocytes. Blood 1996; 8& 1206–1214.
  • Al-Shami A, Mahanna W, Nacake PH. Granulocyte-macro-phage colony-stimulating factor activated signaling pathways in human neutrophils. Selective activation of JAK2, STAT5b, and STAT3. J Biol Chem 1998; 273: 1058–1063.
  • Linden M, Brattsand R. Effect of a corticosteroid, budenoside, on alveolar macrophage and blood monocyte secretion of cytokines: differential sensitivity of GM-CSF, IL-113 and IL-6. Pul Pharmaco11994; 7: 43–47.
  • Joyce DA, Steer JH, Abraham LJ. Glucocorticoid modulation of human monocyte/macrophage function: control of TNF-alpha secretion. Inflamm Res 1997; 46: 447–451.
  • Alwawi WY, Beyhum HN, Rahme AA, Rieder MJ. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J Leuk Biol 1996; 60: 563–572.
  • Moynihan JA, Callahan TA, Kelley SP, Campbell LM. Adrenal hormone modulation of type 1 and type 2 cytokine production by spleen cells: dexamethasone and dehydroepiandrosterone suppress interleukin-2, interleukin-4, and interferon gamma production in vitro. Cell Immunol 1998; 184: 58–64.
  • Ala-Aoukaty A, Giaid A, Sinoff C, Ho AD, Maghazachi AA. Priming effects of granulocyte-macrophage colony-stimulating factor are coupled to cholera toxin-sensitive guanine nucleotide binding protein in human T lymphocytes. Blood 1994; 83: 1299–1309.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.